Miami-based Nicklaus Children’s Hospital’s Heart Institute has become the first in South Florida to offer the FDA-approved Minima stent, a first-of-its-kind cardiac heart stent designed to expand as a child grows, according to an Aug. 28 system news release.
Developed by Newport Beach. Calif.-based Renata Medical, the stent system is built for children with congenital heart disease to address conditions such as coarctation of the aorta and branch pulmonary stenosis. Unlike adult stents, it can be safely dilated over time to reach adult size, reducing the need for repeated open-heart surgeries.
“This represents a new era in how we care for children with congenital heart disease,” said Daniel Duarte Caceres, MD, congenital interventional cardiologist and medical director of interventional cardiology at Nicklaus Children’s, in the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
